We are live on ! Find out more
BAM

Baldrige Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 5.81%
This Fund
S&P 500
This Quarter Est. Return
+6.23%
1 Year Est. Return
-5.81%
3 Year Est. Return
+43.46%
5 Year Est. Return
10 Year Est. Return
AUM
$231M
AUM Growth
+$47.9M
Cap. Flow
+$35.8M
Cap. Flow %
15.51%
Top 10 Hldgs %
46.28%
Holding
355
New
270
Increased
41
Reduced
36
Closed

Sector Composition

Rank Sector Weight
1 Financials 9.7%
2 Technology 4.96%
3 Materials 2.66%
4 Healthcare 1.04%
5 Utilities 0.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNAP icon
326
Snap
SNAP
$7.96B
$3K ﹤0.01%
+50
New +$3K
UBER icon
327
Uber
UBER
$145B
$3K ﹤0.01%
+50
New +$2.61K
VNT icon
328
Vontier
VNT
$4.54B
$3K ﹤0.01%
+89
New +$2.93K
CMPS
329
Compass Pathways
CMPS
$1.47B
$2K ﹤0.01%
+40
New +$1.43K
CSCO icon
330
Cisco
CSCO
$443B
$2K ﹤0.01%
+40
New +$2.1K
CSX icon
331
CSX Corp
CSX
$94B
$2K ﹤0.01%
+57
New +$1.88K
CVS icon
332
CVS Health
CVS
$135B
$2K ﹤0.01%
+29
New +$2.38K
IP icon
333
International Paper
IP
$22.6B
$2K ﹤0.01%
+41
New +$2.34K
LMT icon
334
Lockheed Martin
LMT
$131B
$2K ﹤0.01%
+6
New +$2.31K
PTON icon
335
Peloton Interactive
PTON
$2.85B
$2K ﹤0.01%
+20
New +$2.13K
RBLX icon
336
Roblox
RBLX
$35.9B
$2K ﹤0.01%
+20
New +$1.61K
XBI icon
337
State Street SPDR S&P Biotech ETF
XBI
$10B
$2K ﹤0.01%
+14
New +$1.84K
MMP
338
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2K ﹤0.01%
+50
New +$2.42K
BB icon
339
BlackBerry
BB
$4.58B
$1K ﹤0.01%
+110
New +$1.15K
BBC icon
340
Virtus Biotech Clinical Trials ETF
BBC
$46M
$1K ﹤0.01%
+23
New +$1.13K
BFLY icon
341
Butterfly Network
BFLY
$1.86B
$1K ﹤0.01%
+64
New +$864
CNCR
342
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
$1K ﹤0.01%
+37
New +$1.12K
COMT icon
343
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.19B
$1K ﹤0.01%
+23
New +$751
CRON
344
Cronos Group
CRON
$1.07B
$1K ﹤0.01%
+75
New +$620
F icon
345
Ford
F
$60.9B
$1K ﹤0.01%
+100
New +$1.33K
ITM icon
346
VanEck Intermediate Muni ETF
ITM
$2.14B
$1K ﹤0.01%
+22
New +$1.14K
LYFT icon
347
Lyft
LYFT
$5.86B
$1K ﹤0.01%
+10
New +$575
PBE icon
348
Invesco Biotechnology & Genome ETF
PBE
$286M
$1K ﹤0.01%
+17
New +$1.26K
ARKK icon
349
ARK Innovation ETF
ARKK
$5.59B
$0 ﹤0.01%
+3
New +$350
BHF icon
350
Brighthouse Financial
BHF
$3.61B
$0 ﹤0.01%
+3
New +$141

Similar funds

Baldrige Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Baldrige Asset Management held 355 positions worth $231M, up 26% from $183M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Baldrige Asset Management deployed $35.8M of net new capital in Q2 2021, opening 270 new positions and adding to 41 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 663,726 shares worth $17.9M.

By sector, the portfolio is most concentrated in Financials at 9.7% of assets, up from 9.5% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Air Products & Chemicals, an estimated $901K trimmed.

  • Baldrige Asset Management's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 663,726 shares worth $17.9M.
  • Baldrige Asset Management added most to Vanguard Short-Term Corporate Bond ETF in Q2 2021, an estimated $968K increase.
  • Baldrige Asset Management's biggest Q2 2021 reduction was Air Products & Chemicals, cutting an estimated $901K.
  • Baldrige Asset Management's ten largest holdings make up 46% of its $231M portfolio in Q2 2021.
  • Baldrige Asset Management opened 270 new positions and closed 0 in Q2 2021.
  • Baldrige Asset Management's portfolio value rose 26% quarter-over-quarter to $231M.

Based on Baldrige Asset Management's 13F filing for Q2 2021, filed 3 Aug 2021.